Basic Tenormin Information

• INN (International Nonproprietary Name): Atenolol
• Brand Names Available In Canada (English): Tenormin (originator) and multiple generics supplied globally such as TEVA‑Atenolol, RIVA‑Atenolol, Zentiva and Sandoz (local Canadian brand listings not specified)
• ATC Code: C07AB03
• Forms & Dosages: Tablet, 25 mg / 50 mg / 100 mg; common packages include blisters or bottles (28–100 tablets)
• Manufacturers In Canada (English): AstraZeneca (originator Tenormin) and global generic manufacturers such as Zentiva, Sandoz, Teva, Accord, Normon, Mylan (local distributor SKUs not specified)
• Registration Status In Canada (English): Not specified in the provided data
• OTC / Rx Classification: Prescription‑only (Rx) in all EU/US/major markets per source data

Latest Research Highlights (Canadian & International 2022–2025)

What should patients and clinicians know about atenolol research from 2022–2025?

Recent studies emphasise atenolol’s predominantly renal clearance and the need for careful dose adjustment in people with reduced creatinine clearance.

Canadian pharmacoepidemiology reports and international observational cohorts highlighted dosing and monitoring gaps in older adults with reduced CrCl.

Meta‑analyses from this period continued to show reliable blood pressure lowering with atenolol but suggested cardiovascular outcome benefits may be comparable or slightly less favourable versus some newer cardioselective beta‑blockers in certain high‑risk groups.

Small Canadian hospital audits (post‑2020) observed post‑MI secondary prevention regimens using atenolol 100 mg/day and identified rural adherence gaps linked to pharmacy access.

Guideline updates in this window stressed individualised beta‑blocker selection, routine frailty screening, and specific renal cutoffs for dose changes.

Data Highlight: Renal dosing thresholds used in recent guidance — CrCl 15–35 mL/min: max 50 mg once daily; CrCl <15 mL/min or dialysis: 25 mg once daily or less.

Patient‑centred care now includes shared decision‑making about common side effects such as fatigue and bradycardia and discussion of alternatives like metoprolol or bisoprolol.

Clinical Effectiveness In Canada

How is atenolol used within Canadian practice and formularies?

Health Canada data within the provided source is not specified for Canada by name, but atenolol (INN: atenolol; Tenormin as brand) is listed as an established selective beta‑blocker with standard indications that align with international approvals.

Typical Canadian clinical uses mirror global approvals: hypertension, chronic stable angina, secondary prevention after myocardial infarction, and some arrhythmias under specialist guidance.

Provincial formularies vary and many list generic atenolol supplied by manufacturers such as TEVA‑Atenolol or other generics on general benefit lists; some provinces favour alternatives for first‑line hypertension.

Approved Indications

Hypertension; chronic stable angina; secondary prevention after myocardial infarction; selected arrhythmias (specialist‑directed).

Off‑Label Uses

Short‑term symptomatic control of anxiety‑related tachycardia and adjunct control in symptomatic hyperthyroidism (evidence variable).

Formulary Status By Province

Specific DINs and coverage differ by province; check the Health Canada Drug Product Database and local formularies (ODB, BC PharmaCare, RAMQ) for current listings and prior authorisation requirements.

Clinical dosing commonly starts at 50 mg once daily with up‑titration to 100 mg/day when indicated, taking renal adjustments into account.

Prescribers should consider frailty, diabetes (hypoglycaemia masking), and asthma/COPD risks before initiating atenolol.

Patients should ask their pharmacist whether Tenormin brand or an interchangeable generic is covered under ODB, BC PharmaCare or RAMQ and whether prior authorisation is required for a specific DIN.

Indications And Expanded Uses

What is atenolol approved to treat, and when is it used off‑label?

• Approved Indications: Hypertension — start 50 mg once daily; max 100 mg/day.
• Approved Indications: Angina pectoris — typical range 50–100 mg/day.
• Approved Indications: Post‑myocardial infarction — common regimen 100 mg/day after stabilisation.
• Specialist‑Guided: Some arrhythmias — dosing 50–100 mg and specialist oversight required.
• Off‑Label/Conditional: Anxiety‑related palpitations, perioperative rate control under cardiology guidance, adjunct therapy in symptomatic hyperthyroidism.

Safety caveat: use in patients with asthma or COPD requires specialist oversight because of bronchospasm risk.

Patients crossing provincial lines or visiting border pharmacies should carry a complete medication list and confirm bilingual labelling where required.

Composition And Brand Landscape

Which products and manufacturers supply atenolol in standard strengths?

The active ingredient is atenolol (INN) and the originator brand is Tenormin from AstraZeneca.

Tablet strengths commonly available are 25 mg, 50 mg and 100 mg in blister packs or bottles.

ATC C07AB03

Cardiovascular system → Beta blocking agents → Selective beta‑blockers → Atenolol.

DIN (Drug Identification Number)

Specific DINs vary by product and distributor; reference the Health Canada Drug Product Database for exact current DINs.

Pharmacists should check product monographs for excipients if allergies are a concern and ensure bilingual labels for patients in Quebec.

Cultural note: some Indigenous and remote communities receive bulked supplies through territorial health services, and counselling should be adapted to local follow‑up capabilities.

Contraindications And Special Precautions

Who should not take atenolol, and who needs extra caution?

• Absolute Contraindications: Sinus bradycardia, heart block greater than first degree, overt cardiac failure, cardiogenic shock, severe peripheral arterial circulatory disorders, known hypersensitivity to atenolol or excipients.
• Relative Contraindications (Monitor Closely): Asthma/COPD, diabetes (may mask hypoglycaemia), pheochromocytoma, peripheral vascular disease, untreated adrenal tumours, history of anaphylaxis.

Elderly & Renal Impairment: Start at 25 mg/day in frail older adults and titrate carefully with renal monitoring.

Health authorities recommend ECG and renal function assessment before initiating atenolol when conduction disease or renal impairment is suspected.

High‑risk Canadian groups include the very elderly with polypharmacy, patients in remote or Indigenous communities with limited lab access, and people with unstable diabetes.

Pharmacist‑led medication reviews under provincial programs such as MedsCheck in Ontario are useful to identify and manage these risks.

Dosage Guidelines

What dosing rules apply in routine Canadian care?

Standard dosing: hypertension usually starts at 50 mg once daily, titrating to a usual maximum of 100 mg/day where indicated.

Angina dosing commonly ranges from 50–100 mg/day and post‑MI regimens frequently use 100 mg/day after clinical stabilisation.

Elderly patients should start at 25 mg/day and titrate slowly due to increased sensitivity.

• Monitoring checkpoints: baseline heart rate and blood pressure, renal function, diabetes education for hypoglycaemia masking, and ECG if conduction disease suspected.

Pharmacist tip: check provincial formularies for dosing guidance and any prior‑authorisation dose caps that may affect coverage.

Patient instruction: if a dose is missed, take it as soon as remembered unless it is close to the next dose; do not double up.

Interactions Overview

Which medicines and substances interact with atenolol?

Atenolol interacts primarily through additive heart rate and blood pressure effects rather than hepatic CYP interactions because it is minimally metabolised by the liver.

• High‑Risk Combinations: Verapamil and diltiazem can cause additive bradycardia or heart block when combined with atenolol.
• Other Antihypertensives: Concomitant use increases hypotension risk and requires close monitoring of blood pressure.
• Antiarrhythmics: Some agents can amplify conduction slowing when combined with atenolol.

Alcohol and recreational drugs that lower blood pressure can intensify hypotension when taken with atenolol, and heavy caffeine can complicate symptom recognition.

Over‑the‑counter cold medicines containing decongestants may raise blood pressure and should be discussed with a pharmacist before combining with atenolol.

Patients who buy or receive medication across the border should bring a full medicine list to their Canadian pharmacist to check for interactions and differences in excipients.

Cultural Perceptions And Patient Habits

What do Canadian patients say about Tenormin and atenolol online?

Common patient themes include concerns about fatigue and low energy, questions about switching from Tenormin brand to generic atenolol, and frustration about rural access for monitoring and refills.

• Common Patient Concerns: Fatigue, bradycardia, switching brands, out‑of‑pocket costs when coverage differs.
• Counselling Points: Explain expected side effects, importance of renal monitoring, and reassure on dose adjustments for older adults.

Urban patients often access same‑day pharmacist counselling at large chains like Shoppers Drug Mart, Rexall or London Drugs, while rural patients rely more on telepharmacy or community nursing services.

Bilingual documentation is important in Quebec and parts of New Brunswick, and culturally safe care with community health workers is valuable in Indigenous communities.

Patients benefit from pharmacist‑provided adherence aids such as blister packs, dose synchronisation, and provincial chronic disease supports.

Availability And Pricing Patterns

Where can Canadians find Tenormin or atenolol and what affects price?

Major national chains commonly stock Tenormin and generic atenolol in standard strengths of 25 mg, 50 mg and 100 mg.

Online Canadian pharmacies may dispense atenolol with a prescription and consumers should confirm certification such as CIPA or provincial licensing before ordering.

In our online pharmacy, tenormin is available without a prescription, with discreet delivery to Canada (English) in 5–14 days.

Cross‑border purchases from the US may be less expensive for some strengths, but importation rules, excipient differences and customs should be checked with a pharmacist.

Generics are generally markedly cheaper and substitution is common unless clinicians request brand continuity for stability reasons.

Comparable Medicines And Prescribing Preferences In Canada

Which beta‑blockers are commonly used as alternatives in Canadian practice?

Prescriber choice often depends on comorbid conditions such as heart failure, asthma/COPD risk, renal clearance considerations and formulary coverage.

Atenolol may be chosen for straightforward hypertension when renal dosing is manageable, while bisoprolol or metoprolol are often preferred in heart failure care.

Ask patients about prior experiences with fatigue, sexual dysfunction or sleep disturbance and whether provincial coverage would favour a specific generic alternative.

Frequently Asked Questions

Q: Can I switch from Tenormin to a generic?

A: Yes in most cases; ask your pharmacist to confirm the DIN and provincial coverage and monitor for tolerability after the change.

Q: Is atenolol safe if I have diabetes?

A: Atenolol can mask some symptoms of hypoglycaemia such as a racing heart; more frequent glucose monitoring and patient education are recommended.

Q: I live rurally—how do I get bloodwork for dosing?

A: Arrange local community nursing or lab phlebotomy and discuss longer‑supply synchronisation with your pharmacy to cover refill or access delays.

Q: Can I buy Tenormin in the US and bring it home?

A: Cross‑border purchases may be cheaper but check Health Canada rules and consult your pharmacist about formulation and excipient differences before importing.

Q: What symptoms require emergency care?

A: Severe dizziness, fainting, chest pain, extreme shortness of breath, or signs of severe bradycardia require immediate medical attention.

Data Highlight: If you experience fainting, severe breathlessness, or chest pain while on atenolol seek emergency care right away.

Quebec patients should request bilingual counselling materials where required.

Guidelines For Proper Use

How should pharmacists, prescribers and patients manage atenolol safely?

• Verify the indication, baseline heart rate/blood pressure and renal function before dispensing atenolol.
• Counsel patients on expected side effects such as fatigue, cold extremities and dizziness and review missed‑dose instructions.
• Reconcile all OTC medicines and advise about decongestants and alcohol that may affect blood pressure.

Provincial tips: apply for coverage via ODB, BC PharmaCare or RAMQ and document any prior authorisation requirements in the patient file.

For Indigenous and remote settings, coordinate with community health nurses to ensure follow‑up labs and adherence supports such as blister packs and pharmacist renewals.

Storage: keep at room temperature between 15–30°C, protected from moisture and light.

When switching beta‑blockers avoid sudden withdrawal and titrate under prescriber supervision.

Delivery Across Canada (English)